Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Lorenza Rimassa, Maxime Ronot, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 31
Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 24, pp. 3466-3482
Open Access | Times Cited: 28
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. e67-e161
Open Access | Times Cited: 4
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rafael S. Rios, Kenneth I. Zheng, Ming‐Hua Zheng
Chinese Medical Journal (2021) Vol. 134, Iss. 24, pp. 2911-2921
Open Access | Times Cited: 27
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 02, pp. e82-e158
Closed Access
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. e159-e260
Closed Access
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02, pp. e213-e282
Open Access | Times Cited: 3
Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection
Gu‐Wei Ji, Ye Fan, Dongwei Sun, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 913-923
Open Access | Times Cited: 19
Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic
Sonya L. Bennett, Kjetil Søreide, Sepideh Gholami, et al.
Current Oncology (2020) Vol. 27, Iss. 5, pp. 501-511
Open Access | Times Cited: 18
Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
Tian-Cheng Wang, Tian-Zhi An, Jun‐Xiang Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 11
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
Sabrina Voesch, Michael Bitzer, Albert Jörg, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. e56-e130
Open Access | Times Cited: 7
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study
Lea Penzkofer, Jens Mittler, Stefan Heinrich, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5802-5802
Open Access | Times Cited: 4
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 04, pp. e92-e156
Open Access | Times Cited: 2
Prognostication algorithm for non-cirrhotic non-B non-C hepatocellular carcinoma—a multicenter study under the aegis of the French Association of Hepato-Biliary Surgery and liver Transplantation
Charlotte Maulat, Stéphanie Truant, Christian Hobeika, et al.
HepatoBiliary Surgery and Nutrition (2022) Vol. 12, Iss. 2, pp. 192-204
Open Access | Times Cited: 3
SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer
Runmin Cao, Honghe Jiang, Guangpeng Liang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 12033-12045
Open Access | Times Cited: 1


Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01
Open Access


Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02
Open Access
Aktueller Stand der operativen Therapie des hepatozellulären Karzinoms
Felix Oldhafer, Florian W. R. Vondran, Jens Mittler, et al.
Der Onkologe (2022) Vol. 28, Iss. 4, pp. 278-286
Closed Access | Times Cited: 1


Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 04
Open Access
Comentario editorial sobre carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México
Carlos Moctezuma‐Velázquez
Revista de Gastroenterología de México (2020) Vol. 86, Iss. 1, pp. 1-3
Open Access


Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01
Open Access
Operative Therapiestrategien bei primären Lebertumoren, hepatozellulären und Cholangio- inkl. Gallenblasenkarzinomen
Silvio Nadalin, Maren Peters, Alfred Königsrainer
Allgemein- und Viszeralchirurgie up2date (2022) Vol. 16, Iss. 04, pp. 313-331
Closed Access
Editorial comment on hepatocellular carcinoma in the noncirrhotic liver: Clinical characteristics and results in Veracruz, Mexico
Carlos Moctezuma‐Velázquez
Revista de Gastroenterología de México (English Edition) (2021) Vol. 86, Iss. 1, pp. 1-3
Open Access
Page 1

Scroll to top